Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity
- PMID: 24642735
- DOI: 10.1038/clpt.2014.67
Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity
Comment in
-
Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".Clin Pharmacol Ther. 2014 Aug;96(2):158. doi: 10.1038/clpt.2014.90. Epub 2014 Apr 22. Clin Pharmacol Ther. 2014. PMID: 24755913 No abstract available.
Comment on
-
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.Clin Pharmacol Ther. 2013 Aug;94(2):243-51. doi: 10.1038/clpt.2013.80. Epub 2013 Apr 10. Clin Pharmacol Ther. 2013. PMID: 23588304 Free PMC article.
-
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.Clin Pharmacol Ther. 2013 Aug;94(2):252-9. doi: 10.1038/clpt.2013.121. Epub 2013 Jun 11. Clin Pharmacol Ther. 2013. PMID: 23820299 Free PMC article.
-
Genetics of cisplatin ototoxicity: confirming the unexplained?Clin Pharmacol Ther. 2013 Aug;94(2):198-200. doi: 10.1038/clpt.2013.116. Clin Pharmacol Ther. 2013. PMID: 23872836
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
